You are here
- Home
Total number of clinical trials
- collapse A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA) 300 mg in Patients with Papillary or Poorly Differentiated Thyroid Cancer That Is Either Locally Advanced or Metastatic Who Are Refractory or Unsuitable for Radioiodine (RAI) Therapy.
- collapse Phase III Randomised, Double Blind, Placebo Controlled Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed BRCA Mutated Ovarian Cancer Patients with a Complete or Partial Response Following Platinum based Chemotherapy
- collapse TIGRIS: Long-Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease in post myocardial infarction patients
- collapse A study to evaluate the use of mobile-phone based patient support in patients diagnosed with Myocardial Infarction - SUPPORT
- collapse A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients with Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants.
- collapse A Randomized, Double-Blind, Two-Period Crossover Study to Assess Safety, Tolerability, and Pharmacokinetics Following Repeated Doses of AZD6140 (400 mg od) and Digoxin (0.25 mg od) in Healthy Male and Female Volunteers
- collapse ProAcor: Prospective Structured Care In Acute Coronary Syndrome Registry
- collapse A multicenter, single arm, open label, Phase IV study to evaluate safety and to describe the incidence of major cardiovascular events of ticagrelor in Chinese patients with acute coronary syndrome
- collapse An Efficacy and 2-Year Safety Study of Open-label Rosuvastatin in Children and Adolescents (Aged From 6 to Less Than 18 Years) With Familial Hypercholesterolaemia
- collapse Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)
